Search results
The inhibitory effect of miR-377 on prostate cancer cells
Medical Xpress· 5 days agoA new research paper titled "Inhibitory effect of miR-377 on the proliferative and invasive behaviors of prostate cancer cells through the modulation of ...
Prostate Cancer Screening: What Does Your Patient Fear Most?
Medscape· 4 days agoDr Neil Skolnik distills available recommendations (including recent AUA guidance) to help...
Ipswich man's small mole led to skin cancer and seven surgeries
BBC News· 8 hours agoBack in 2012, John Cleeton could never have imagined that a mole, smaller than his little finger's...
...Photoimmunotherapy in Combination with anti-PD-1 for First Line Recurrent and/or Metastatic Head...
Yucaipa News Mirror· 2 days agoRakuten Medical, Inc., a global biotechnology company developing and commercializing precision, cell-targeting photoimmunotherapy based on its proprietary Alluminox™ platform ...
3 hospitals piloting blood tests to detect cancer
Becker’s Hospital Review· 5 days agoMore hospitals and systems are testing the effectiveness of blood tests to detect cancer. Recently, the Prostate Cancer Foundation also ...
Ipilimumab, a Pioneer Breakthrough in Cancer Treatment
Forbes· 6 days agoIn 2011, the first in a new generation of anticancer drugs called checkpoint inhibitors was...
Cedars-Sinai Experts Present Cancer News at ASCO A | Newswise
Newswise· 2 days agoCedars-Sinai Cancer physician-scientists and thought leaders will discuss scientific advances, new therapies, and the future of cancer care at the American
What Happens to Your Body When You Eat Broccoli Regularly
Eating Well via Yahoo News· 3 days agoThe Bottom Line When you consume broccoli regularly, you provide your body with a plethora of...
Rutgers Cancer Institute and RWJBarnabas Health Se | Newswise
Newswise· 3 days agoClinicians and scientists from Rutgers Cancer Institute and RWJBarnabas Health will lead sessions...
ASCO24: An early look at cancer drug study results
BioPharma Dive via Yahoo Finance· 3 days agoClinical trial abstracts posted Thursday ahead of this year’s ASCO meeting give a peek at anticipated datasets from Immunocore, Merus, J&J and Merck &...